H.C. Wainwright maintained a positive stance on Esperion Therapeutics (NASDAQ:ESPR) shares, reaffirming a Buy rating and a price target of $16.00. According to InvestingPro data, analyst targets for ...

NASA scientists continuously track asteroids that pass near Earth to assess potential risks. After three asteroids—2025 CJ3, ...

Once again, Tata Motors topped the list of CV retail sales Jan 2025 though it suffered a marginal de-growth to command a ...

Report with market evolution powered by AI - The global mexican food market size is estimated to grow by USD 104.8 billion ...

Following Q3FY25 results, Eicher Motors’ stock dropped nearly 7% as Goldman Sachs lowered its target price. The company ...

Retail pharmacy giant Walgreen Co must pay more than $987 million to satisfy an arbitration award won by telemedicine ...

Michigan State University athletics experienced a weekend of highs and lows, with dominant victories in men’s basketball, ...

The nominees, announced during Monday’s plenary by the Speaker of the Assembly, Rt. Hon. Danladi Jatau, include six former cabinet ...

West Bengal Governor CV Ananda Bose praised Chief Minister Mamata Banerjee's leadership and highlighted the state's ...

National Apprenticeship Week (NAW) is an annual event that celebrates apprenticeships and the impact they have on individuals ...

By submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.